Literature DB >> 28289760

PTEN proteoforms in biology and disease.

Prerna Malaney1, Vladimir N Uversky2,3, Vrushank Davé4,5.   

Abstract

Proteoforms are specific molecular forms of protein products arising from a single gene that possess different structures and different functions. Therefore, a single gene can produce a large repertoire of proteoforms by means of allelic variations (mutations, indels, SNPs), alternative splicing and other pre-translational mechanisms, post-translational modifications (PTMs), conformational dynamics, and functioning. Resulting proteoforms that have different sizes, alternative splicing patterns, sets of post-translational modifications, protein-protein interactions, and protein-ligand interactions, might dramatically increase the functionality of the encoded protein. Herein, we have interrogated the tumor suppressor PTEN for its proteoforms and find that this protein exists in multiple forms with distinct functions and sub-cellular localizations. Furthermore, the levels of each PTEN proteoform in a given cell may affect its biological function. Indeed, the paradigm of the continuum model of tumor suppression by PTEN can be better explained by the presence of a continuum of PTEN proteoforms, diversity, and levels of which are associated with pathological outcomes than simply by the different roles of mutations in the PTEN gene. Consequently, understanding the mechanisms underlying the dysregulation of PTEN proteoforms by several genomic and non-genomic mechanisms in cancer and other diseases is imperative. We have identified different PTEN proteoforms, which control various aspects of cellular function and grouped them into three categories of intrinsic, function-induced, and inducible proteoforms. A special emphasis is given to the inducible PTEN proteoforms that are produced due to alternative translational initiation. The novel finding that PTEN forms dimers with biological implications supports the notion that PTEN proteoform-proteoform interactions may play hitherto unknown roles in cellular homeostasis and in pathogenic settings, including cancer. These PTEN proteoforms with unique properties and functionalities offer potential novel therapeutic opportunities in the treatment of various cancers and other diseases.

Entities:  

Keywords:  Alternative translational initiation; PTEN; Post-translational modifications; Proteoforms

Mesh:

Substances:

Year:  2017        PMID: 28289760     DOI: 10.1007/s00018-017-2500-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  63 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.

Authors:  Shipra Agrawal; Charis Eng
Journal:  Hum Mol Genet       Date:  2006-01-25       Impact factor: 6.150

3.  Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  Debasmita Roy; Dirk P Dittmer
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

4.  Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

Authors:  Antonella Papa; Lixin Wan; Massimo Bonora; Leonardo Salmena; Min Sup Song; Robin M Hobbs; Andrea Lunardi; Kaitlyn Webster; Christopher Ng; Ryan H Newton; Nicholas Knoblauch; Jlenia Guarnerio; Keisuke Ito; Laurence A Turka; Andy H Beck; Paolo Pinton; Roderick T Bronson; Wenyi Wei; Pier Paolo Pandolfi
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

Review 5.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 6.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

7.  A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop.

Authors:  S Fernández; L Genis; I Torres-Alemán
Journal:  Oncogene       Date:  2013-09-23       Impact factor: 9.867

8.  Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain.

Authors:  Leticia Odriozola; Gobind Singh; Thuong Hoang; Andrew M Chan
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157

9.  GWIPS-viz as a tool for exploring ribosome profiling evidence supporting the synthesis of alternative proteoforms.

Authors:  Audrey M Michel; Anna M Ahern; Claire A Donohue; Pavel V Baranov
Journal:  Proteomics       Date:  2015-04-23       Impact factor: 3.984

10.  Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension.

Authors:  Henrick Horita; Seth B Furgeson; Allison Ostriker; Kyle A Olszewski; Timothy Sullivan; Leah R Villegas; Michelle Levine; Jane E Parr; Carlyne D Cool; Raphael A Nemenoff; Mary C M Weiser-Evans
Journal:  J Am Heart Assoc       Date:  2013-05-31       Impact factor: 5.501

View more
  27 in total

Review 1.  The Structural and Functional Diversity of Intrinsically Disordered Regions in Transmembrane Proteins.

Authors:  Rajeswari Appadurai; Vladimir N Uversky; Anand Srivastava
Journal:  J Membr Biol       Date:  2019-05-28       Impact factor: 1.843

2.  The diagnostic role of PTEN and ARID1A in serous effusions.

Authors:  Ben Davidson; Maurizio Pinamonti; Dolors Cuevas; Arild Holth; Pio Zeppa; Thomas Hager; Jeremias Wohlschlaeger; Martin Tötsch
Journal:  Virchows Arch       Date:  2017-11-24       Impact factor: 4.064

Review 3.  Lipid droplet and its implication in cancer progression.

Authors:  Zhenzhen Li; Huiwen Liu; Xiangjian Luo
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers.

Authors:  Qinyi Wang; Junmin Wang; Hongjiao Xiang; Peilun Ding; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

5.  PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.

Authors:  Prerna Malaney; Emily Palumbo; Jonathan Semidey-Hurtado; Jamaal Hardee; Katherine Stanford; Jaymin J Kathiriya; Deepal Patel; Zhi Tian; Diane Allen-Gipson; Vrushank Davé
Journal:  Cell Cycle       Date:  2018-05-31       Impact factor: 4.534

Review 6.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

7.  Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway.

Authors:  Pradeep Kumar; Reben Raeman; Daniel M Chopyk; Tekla Smith; Kiran Verma; Yunshan Liu; Frank A Anania
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-08-08       Impact factor: 5.187

8.  Proteomics in Non-model Organisms: A New Analytical Frontier.

Authors:  Michelle Heck; Benjamin A Neely
Journal:  J Proteome Res       Date:  2020-08-20       Impact factor: 4.466

9.  miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog.

Authors:  Meiyi Song; Mengxue Sun; Lu Xia; Wei Chen; Changqing Yang
Journal:  Ann Transl Med       Date:  2019-06

10.  MiR-17-5p promotes the endothelialization of endothelial progenitor cells to facilitate the vascular repair of aneurysm by regulating PTEN-mediated PI3K/AKT/VEGFA pathway.

Authors:  Ye Tian; Xinxi Li; Chao Bai; Zhenwei Yang; Lei Zhang; Jun Luo
Journal:  Cell Cycle       Date:  2020-12-14       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.